FDA to Consider Foreign Drug Importation When Lack of Competition or Supply Problems Threaten Access

The FDA is forming a work group to consider situations under which the FDA would allow the importation of drugs that would be suitable substitutes for the FDA-approved version of medically-necessary drugs. The initiative comes as a result of recognizing that in some situations access to older drugs that are not in wide use but may be medically necessary can be threatened by significant price increases or disruptions in supply chains.